BSE Code: | NSE Code: | ISIN: | Sector:
Research Report Detail
|Report Date||Call||Price@Call||Target Price
|Current Status||Time Horizon|
|Bank of America Merrill Lynch
|Target Hit|| Long (1Y)
Bank of America Merrill Lynch upgrades Sun Pharma to buy
The brokerage says current valuation presents better entry point as the Street is factoring in a worst-case outcome at Halol plant. Competition Commission of India approval clears major hurdle for Sun Pharma-Ranbaxy merger, adds the brokerage.